Cubist Systematic Strategies’s Hims & Hers Health HIMS Stock Holding History

Cubist Systematic Strategies’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$55.6M	Sell	979,700 -182,800	-16%	-$9.37M	0.26%	47
2025 Q2	$58M	Buy	1,162,500 +530,600	+84%	+$24M	0.27%	42
2025 Q1	$18.7M	Buy	631,900 +381,800	+153%	+$14.2M	0.11%	221
2024 Q4	$6.05M	Sell	250,100 -294,400	-54%	-$7.29M	0.04%	719
2024 Q3	$10M	Buy	544,500 +51,600	+10%	+$924K	0.06%	459
2024 Q2	$9.95M	Buy	492,900 +423,300	+608%	+$7.04M	0.07%	415
2024 Q1	$1.08M	Buy	+69,600	New	+$785K	0.01%	2105
2023 Q4	–	Sell	-58,700	Closed	-$369K	–	3791
2023 Q3	$369K	Sell	58,700 -33,200	-36%	-$247K	﹤0.01%	2486
2023 Q2	$864K	Buy	91,900 +68,600	+294%	+$680K	0.01%	2046
2023 Q1	$231K	Buy	+23,300	New	+$204K	﹤0.01%	3153

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's HIMS Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Hims & Hers Health (HIMS) in Q2 2024, closing a stake of 1,087,247 shares — an estimated $18.1M sold.

Cubist Systematic Strategies first reported a position in HIMS in Q4 2020 and held it in 14 quarters. The position peaked at $16.8M in Q1 2024. 297 funds tracked by Wall St. Rank hold HIMS as of Q2 2024.

Cubist Systematic Strategies reported no remaining Hims & Hers Health position as of Q2 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 1,087,247 Hims & Hers Health shares in Q2 2024, an estimated $18.1M.
Cubist Systematic Strategies first reported a position in Hims & Hers Health in Q4 2020 and held it in 14 quarters.
Cubist Systematic Strategies's Hims & Hers Health position peaked at $16.8M in Q1 2024.
297 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.